If nausea is limiting, the lever is the schedule, and that lever belongs to your prescriber
Recently, there has been growing interest in compounds such as BPC-157available in both injectable and oral forms (including capsules)for their potential roles in pain management and tissue healing
However, some patients report no adverse effects and may not notice symptomatic changes
Since we start low and go slow with the GLP-1 tissue saturation process, the strength, dose, route of administration, may differ from commercially available, brand-name, drugs which makes direct comparisons of results & risk profile between FDA-approved drugs and compounded drugs difficult
This earlier study was uncontrolled, however, but justified the subsequent controlled trial
You do not get the metabolic upside without the rest of the glucagon signature coming along